These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34853030)

  • 41. The antioxidant enzyme Peroxiredoxin-1 controls stroke-associated microglia against acute ischemic stroke.
    Kim S; Lee W; Jo H; Sonn SK; Jeong SJ; Seo S; Suh J; Jin J; Kweon HY; Kim TK; Moon SH; Jeon S; Kim JW; Kim YR; Lee EW; Shin HK; Park SH; Oh GT
    Redox Biol; 2022 Aug; 54():102347. PubMed ID: 35688114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7.
    Hopkins BL; Nadler M; Skoko JJ; Bertomeu T; Pelosi A; Shafaei PM; Levine K; Schempf A; Pennarun B; Yang B; Datta D; Bucur O; Ndebele K; Oesterreich S; Yang D; Giulia Rizzo M; Khosravi-Far R; Neumann CA
    Antioxid Redox Signal; 2018 Jan; 28(1):62-77. PubMed ID: 28398822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.
    Fiskus W; Coothankandaswamy V; Chen J; Ma H; Ha K; Saenz DT; Krieger SS; Mill CP; Sun B; Huang P; Mumm JS; Melnick AM; Bhalla KN
    Cancer Res; 2016 Sep; 76(18):5467-78. PubMed ID: 27503926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxiredoxin as a functional endogenous antioxidant enzyme in pronuclei of mouse zygotes.
    Morita K; Tokoro M; Hatanaka Y; Higuchi C; Ikegami H; Nagai K; Anzai M; Kato H; Mitani T; Taguchi Y; Yamagata K; Hosoi Y; Miyamoto K; Matsumoto K
    J Reprod Dev; 2018 Apr; 64(2):161-171. PubMed ID: 29503398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peroxiredoxin 1 inhibits lipopolysaccharide-induced oxidative stress in lung tissue by regulating P38/JNK signaling pathway.
    Lv WP; Li MX; Wang L
    Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1876-1883. PubMed ID: 28485790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peroxiredoxin 1 - an antioxidant enzyme in cancer.
    Ding C; Fan X; Wu G
    J Cell Mol Med; 2017 Jan; 21(1):193-202. PubMed ID: 27653015
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AMP-dependent kinase inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis by suppressing the dissociation between c-Abl and Prdx1 proteins in endothelial cells.
    Takeuchi K; Morizane Y; Kamami-Levy C; Suzuki J; Kayama M; Cai W; Miller JW; Vavvas DG
    J Biol Chem; 2013 Jul; 288(28):20581-91. PubMed ID: 23723070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma.
    Strecker MI; Wlotzka K; Strassheimer F; Roller B; Ludmirski G; König S; Röder J; Opitz C; Alekseeva T; Reul J; Sevenich L; Tonn T; Wels WS; Steinbach JP; Buchholz CJ; Burger MC
    Oncoimmunology; 2022; 11(1):2127508. PubMed ID: 36249274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of the natural killer (NK) cell modulation in breast cancer incidence and progress.
    Razeghian E; Kameh MC; Shafiee S; Khalafi F; Jafari F; Asghari M; Kazemi K; Ilkhani S; Shariatzadeh S; Haj-Mirzaian A
    Mol Biol Rep; 2022 Nov; 49(11):10935-10948. PubMed ID: 36008609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis.
    Zhao W; Fan GC; Zhang ZG; Bandyopadhyay A; Zhou X; Kranias EG
    Basic Res Cardiol; 2009 Jul; 104(4):377-89. PubMed ID: 19030911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.
    Christodoulou I; Ho WJ; Marple A; Ravich JW; Tam A; Rahnama R; Fearnow A; Rietberg C; Yanik S; Solomou EE; Varadhan R; Koldobskiy MA; Bonifant CL
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34896980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.
    Martinez-Outschoorn UE; Balliet R; Lin Z; Whitaker-Menezes D; Birbe RC; Bombonati A; Pavlides S; Lamb R; Sneddon S; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Dec; 11(23):4402-13. PubMed ID: 23172369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins.
    Wang Z; Cheng Y; Wang N; Wang DM; Li YW; Han F; Shen JG; Yang DP; Guan XY; Chen JP
    Cancer Biol Ther; 2012 Feb; 13(3):138-47. PubMed ID: 22231406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyaluronic acid optimises therapeutic effects of hydrogen peroxide-induced oxidative stress on breast cancer.
    Abbasi A; Pakravan N; Hassan ZM
    J Cell Physiol; 2021 Feb; 236(2):1494-1514. PubMed ID: 32740942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.
    Kisucka J; Chauhan AK; Patten IS; Yesilaltay A; Neumann C; Van Etten RA; Krieger M; Wagner DD
    Circ Res; 2008 Sep; 103(6):598-605. PubMed ID: 18689572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peroxiredoxin 1 and its role in cell signaling.
    Neumann CA; Cao J; Manevich Y
    Cell Cycle; 2009 Dec; 8(24):4072-8. PubMed ID: 19923889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomics of the oxidative stress response induced by hydrogen peroxide and paraquat reveals a novel AhpC-like protein in Pseudomonas aeruginosa.
    Hare NJ; Scott NE; Shin EH; Connolly AM; Larsen MR; Palmisano G; Cordwell SJ
    Proteomics; 2011 Aug; 11(15):3056-69. PubMed ID: 21674802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 59. Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders.
    Goemaere J; Knoops B
    J Comp Neurol; 2012 Feb; 520(2):258-80. PubMed ID: 21674491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences in tolerogenic status of NK cells between luminal A type, luminal B type, and triple-negative breast cancer.
    Starčević A; Grebić D; Avirović M; Mavrinac M; Valković Zujić P; Veljković Vujaklija D; Gulić T
    Neoplasma; 2022 Dec; 69(6):1289-1302. PubMed ID: 36264774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.